Notícias e Atividades da X4 Pharmaceuticals

X4 Pharmaceuticals é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

X4 Pharmaceuticals é uma empresa listada sob o símbolo XFOR (US).

Veja o organograma con seus 19 executivos principais

Biografias mais buscadas da X4 Pharmaceuticals

• Paula Ragan, Director, Chief Executive Officer and President
• Keith Woods, Director
• Gary Bridger, Director

Criar um alerta
para seguir os movimentos de executivos da X4 Pharmaceuticals.

X4 Pharmaceuticals possui 1.834 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Eli Lilly (Estados Unidos).

Popular M&A news in Farmacêutica

• Imbria Pharmaceuticals acaba de anunciar uma arrecadação de fundos de 58 milhões de dólares. (publicado em 10 de abril de 2025).
• Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).
• Knight Therapeutics has announced the acquisition of Paladin Labs  (publicado em 12 de março de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer da Adare Pharmaceuticals
• Seth Harrison - Chairman and Director da Braeburn Pharmaceuticals

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de X4 Pharmaceuticals

• X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update | X4 Pharmaceuticals, Inc.
• X4 Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host a Conference Call and Webcast on August 4, 2022 | X4 Pharmaceuticals, Inc.
• X4 Pharmaceuticals Announces Strategic Prioritization of Programs and Resources Extending Cash Runway Through Expected Key Clinical and Regulatory Milestones | X4 Pharmaceuticals, Inc.
• News Releases | X4 Pharmaceuticals, Inc.
• News Releases | X4 Pharmaceuticals, Inc.
• News Releases | X4 Pharmaceuticals, Inc.
• News Releases | X4 Pharmaceuticals, Inc.
• News Releases | X4 Pharmaceuticals, Inc.
• X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | X4 Pharmaceuticals, Inc.
• X4 Pharmaceuticals Announces $55 Million Private Placement Financing and Debt Facility Amendment Extending Interest-Only Period by up to 12 Months | X4 Pharmaceuticals, Inc.
• View more press releases Close

Redes sociais sobre X4 Pharmaceuticals

• X4 Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• X4 Pharmaceuticals na LinkedIn, Twitter e YouTube